Atorvastatin Calcium Trihydrate 20 mg Tablets
Atorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication
Hwanin Pharmaceutical Co., Ltd.
MFDS item code 201701568 · Approved 2017.03.31 · Insurance code 657203260
Reduces the risk of myocardial infarction and stroke and improves hypercholesterolemia
This medication is used to reduce the risk of cardiovascular diseases. It specifically lowers the risk of myocardial infarction and stroke in adults with risk factors for coronary heart disease and in patients with type 2 diabetes. Additionally, it is effective in reducing the risk of non-fatal myocardial infarction, stroke, vascular surgery, and hospitalization due to congestive heart failure in patients with heart disease. In patients with hyperlipidemia, it helps lower cholesterol, LDL cholesterol, and triglyceride levels while increasing HDL cholesterol. This medication is also used in various types of dyslipidemia that do not respond adequately to diet. It is safe for use in pediatric patients with heterozygous familial hypercholesterolemia and contributes to reducing cardiovascular risk factors. Therefore, it is used for the prevention and improvement of cardiovascular diseases and hyperlipidemia.
For hyperlipidemia treatment, the recommended initial dose is atorvastatin 10 mg once daily; for patients needing more LDL cholesterol reduction, it may be started at 20 mg or 40 mg once daily. The dosage range is 10-80 mg once daily. Lipid levels should be analyzed within 2-4 weeks after initiation and dosage adjustment, and adjustments should be made accordingly. The goal of treatment is to lower LDL cholesterol levels, and it is recommended to use LDL cholesterol levels for treatment initiation and response evaluation. If LDL cholesterol levels are not available, total cholesterol levels should be used to monitor treatment response. For patients with homozygous familial hypercholesterolemia, the dosage is 10-80 mg once daily, either in conjunction with other lipid-lowering treatments (e.g., LDL apheresis) or when such treatments are not feasible.
In pediatric patients (10-17 years) with heterozygous familial hypercholesterolemia, the recommended initial dose is 10 mg once daily, with a maximum dose of 20 mg once daily. The dosage may be adjusted based on the recommended treatment goals over intervals of 4 weeks or more.
This medication may cause unusual symptoms in muscles; if muscle pain or weakness worsens, consult a doctor immediately. This medication should not be used in patients with severe liver disease or in pregnant or nursing women, or children under 10 years of age. Since it may affect liver function, regular liver function tests are necessary, and any unusual liver symptoms should be reported immediately. It is advisable to avoid or reduce alcohol consumption while taking this medication. If taken with certain medications, drug concentrations may increase, raising the risk of side effects, so inform your doctor or pharmacist about other medications being taken. Women of childbearing potential should use appropriate contraceptive methods while taking this medication and discontinue use if pregnancy is confirmed. If muscle-related abnormal symptoms or significantly elevated muscle enzyme levels occur, discontinue the medication and consult healthcare professionals. This medication can cause severe skin reactions; if a rash or blisters develop, discontinue use immediately and seek medical attention. Elderly patients or those with impaired kidney function may have a higher risk of side effects while taking this medication and should be observed closely. This medication should be stored out of the reach of children and in a designated container to prevent misuse or deterioration of quality.
Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, pallor, severe allergic reactions, severe rash with high fever, blisters, skin peeling, pain in mouth/eye mucosa, severe skin adverse reactions, asthma attacks, respiratory issues accompanied by cough and fever, respiratory problem, yellowing of the skin or eyes (jaundice), extreme lethargy, liver abnormalities (jaundice), sudden and severe headache, thunderclap headache
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to protect it from air and moisture. It is important to maintain a storage temperature between 1°C and 30°C. Proper storage will help preserve the medication's efficacy and safety for an extended period.
White round film-coated tablet
100 tablets/bottle, 30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Atorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication
Hwanin Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 43.4mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Kyungdong Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Shinil Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 10.845mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.